Index of artpub/2019/pmc_30892987/

Van Cutsem, Eric
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer : Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
2019
https://ddd.uab.cat/record/230719